To assess the roles of KIAA0100 in breast cancer, its expression in breast cancer cell line MDA-MB-231 was first knocked-down by siRNA targeted to exon 25 in a forward-transfection manner, as indicated in the Methods section below. Here, BLTP2 is linked to breast cancer.